pcn poster

Posters

Long-term Efficacy of Lurasidone in Antipsychotic-Naive vs. Antipsychotic-Exposed Adolescents with Schizophrenia: Post-hoc Analysis of a Two Year, Open-label Study

Background: The aim of this post-hoc analysis was to evaluate the long-term efficacy of lurasidone in antipsychotic-naïve adolescents with schizophrenia.

Robert Goldman , PhD;

Christoph U. Correll , MD;

Andrei Pikalov , MD, PhD;

Michael Tocco , PhD;

Jay Hsu , PhD;

10/08/2020

Palatability Assessment of a New Amphetamine Extended-Release Tablet Formulation

Background Palatability is a positive factor in adherence and persistence with prescribed medication regimens. We assessed palatability for a new amphetamine extended-release tablet (Dya...

Judith Kando , PharmD, BCPP;

Thomas King , MS, MPH;

Antonio Pardo , MD;

Eman Rafla ;

10/08/2020

Humanistic and Economic Burden of Depression in the United States (US)

Objective: This study determined differences in outcomes among respondents with and without a depression diagnosis and across symptom severity in respondents with diagnosed depression. ...

Shaloo Gupta , MS;

Vicky Li , MPH;

Alix Arnaud , MSc;

Ellison Suthoff , MBA, BS ;

10/08/2020

Open-Label, Phase 2 Trial of the Oral Neuroactive Steroid GABAA Receptor Positive Allosteric Modulator Zuranolone in Bipolar Disorder I and II

Background: Bipolar disorder (BPD) is a chronic, episodic illness affecting nearly 50 million globally, with disability mostly due to depressive episodes (MDEs). Zuranolone is an investig...

Handan Gunduz-Bruce , MD, MBA;

Abdul Sankoh , PhD;

Jeffrey Jonas , MD;

Indrani Nandy , PhD;

James Doherty , PhD;

Stephen Kanes , MD, PhD;

Robert Lasser , MD, MBA;

10/08/2020

Hospitalizations, Emergency Room Visits and Adherence Among Patients With Schizophrenia Initiated on Long-Acting Injectable Versus Oral Antipsychotics: A Systematic Review and Meta-Analysis

Long-acting injectable (LAI) antipsychotics, compared with oral antipsychotics (OA), have the potential to increase medication adherence in adult patients with schizophrenia. This increas...

Maria-Helene Lafeuille , MA;

Philippe Thomas-Leduc , MSc;

Isabelle Ghelerter ;

Patrick Lefebvre , MA;

Ha Nguyen , BA;

Dee Lin , PharmD, MS;

Panagiotis Mavros , PhD;

Carmella Benson , MSc, MS, MSHP;

10/08/2020

Onset of Reduction in Depressive Symptoms in Postpartum Depression (PPD): Pivotal Studies of Two Neuroactive Steroid GABAA Receptor Positive Allosteric Modulators, Brexanolone Injection and Zuranolone

Background: Brexanolone injection (BRX) and the investigational compound, zuranolone (SAGE-217; ZRN), two neuroactive steroid (NAS) GABAA receptor positive allosteric modulators, were eva...

Samantha Meltzer-Brody , MD;

Handan Gunduz-Bruce , MD, MBA;

Helen Colquhoun , MD;

Kristina Deligiannidis , MD;

Stephen Kanes , MD, PhD;

10/08/2020

Hospitalization Risk among Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics: A Long-Term Retrospective Analysis of Medicaid Claims Data

Objective: To compare the risk of hospitalization for adults with bipolar I disorder (BPD-I) when treated with lurasidone vs. other atypical antipsychotics (AAPs) as monotherapy.

Jason Shafrin , PhD;

Carole Dembek , MS;

Xiaoli Niu , PhD;

Phani Veeranki , MD, DrPH;

Syvart Dennen , MS;

Yanmei Liu , MS;

Kimberly Laubmeier , PhD;

G.R. Williams , PhD;

10/08/2020

Non-Healthcare Societal Burden of Schizophrenia Among Veterans

Introduction: Schizophrenia (SCZ) is a severe mental disorder imposing substantial healthcare burden to society. Data quantifying the non-healthcare societal burden of SCZ is limited, esp...

Carmella Benson , MSc, MS, MSHP;

Hyunchung Kim ;

Maya Aboumrad , MPH;

Keiko Wada ;

Ethan Powell , BA;

Gabrielle Zwain , BA;

Aimee Near ;

Dee Lin , PharmD, MS;

10/08/2020

Good, moderate, and poor functioning of adult patients with schizophrenia treated with aripiprazole once-monthly or paliperidone palmitate once-monthly in the Qualify study

Introduction QUALIFY was a 28-week, randomized, open-label, rater-blinded, head-to-head study (NCT01795547) evaluating effectiveness of aripiprazole once-monthly (AOM 400) vs paliperidone...

Simon Nitschky Schmidt , PhD;

Lizbeth Arias , MD;

Ross Baker , PhD, MBA;

Pedro Such , MD;

Jessica Madera , MD;

10/08/2020

Medication Adherence, Healthcare Resource Utilization, and Costs Among Medicaid Beneficiaries With Schizophrenia Treated With Once-monthly Paliperidone Palmitate or Once-every-three-months Paliperidone Palmitate

Background: Antipsychotics with reduced dosing frequency may improve adherence and clinical outcomes for patients with schizophrenia. This study compared adherence, persistence, healthcar...

Maryia Zhdanava , MA;

Maria-Helene Lafeuille , MA;

Kruti Joshi , MPH, MD;

Patrick Lefebvre , MA;

Dominic Pilon , MA;

Dee Lin , PharmD, MS;

Aurelie Cote ;

Maude Vermette-Laforme , BSc;

10/08/2020

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Posters

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products